Systemic CD8+ T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Reference-Cited by-同舟云学术

Systemic CD8+ T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor

Published:2014-08-08 Issue:8 Volume:9 Page:e104669
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ishihara Mikiya,Seo Naohiro,Mitsui Jun,Muraoka Daisuke,Tanaka Maki,Mineno Junichi,Ikeda Hiroaki,Shiku Hiroshi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Oncolytic viruses in cancer therapy;MJ Vaha-Koskela;Cancer Lett,2007

2. Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval;CJ Breitbach;Cytokine Growth Factor Rev,2010

3. Clinical development directions in oncolytic viral therapy;RM Eager;Cancer Gene Ther,2011

4. Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF;JH Kim;Mol Ther,2006

5. Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial;BH Park;Lancet Oncol,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy;International Journal of Molecular Sciences;2024-04-25

2. The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies;International Journal of Molecular Sciences;2023-08-28

3. Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?;Journal for ImmunoTherapy of Cancer;2023-08

4. Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model;Scientific Reports;2022-12-13

5. Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8 + PD ‐1 − tumor‐infiltrating T cells in PD‐L1 ‐enriched tumor microenvironment;International Journal of Cancer;2021-03-23